Open AccessAcquired thrombotic thrombocytopenic Purpura diagnosed during first trimester of pregnancy with excellent outcome after plasma exchange and rituximab, a case report
Author(s) -
ArzuagaMendez Javier,
Moreno Maite,
MateosMazón Juan J.,
Vara Miriam,
Dueñas Marta,
Del Orbe Rafael A.,
Amutio Elena,
Arrizabalaga Beatriz,
GarcíaRuiz Juan C.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3752
Subject(s) - medicine , thrombotic thrombocytopenic purpura , rituximab , pregnancy , therapeutic plasma exchange , first trimester , third trimester , pediatrics , obstetrics , gestation , surgery , platelet , immunology , antibody , biology , genetics
Key Clinical Message Acquired thrombotic thrombocytopenic purpura is a life‐threatening condition that rarely presents during pregnancy. Early diagnosis and treatment with plasma exchange is needed to achieve a good pregnancy outcome.